This webinar ended the Research on COVID-19 series bringing some of the results obtained in the fast track call launched by FAPESP in 2020

Webinar presented and discussed actions that have used methods of implementation science to transform the practice of medicine.

The webinar showed the relevance of Artificial Intelligence approaches and the use of COVID-19-related data for controlling the pandemic.

This webinar discussed the challenges of the various sectors involved in the complex Brazilian research ecosystem.

This webinar addressed molecular approaches of the COVID-19 syndrome from both cellular and organismal viewpoints.

While the etiology of subacute COVID-19 remains unclear, disturbed immune responses, viral persistence, neural cell damage may be possible mechanisms.

The webinar detailed the foremost themes, questions and needed research of the agenda that has emerged worldwide as a result of COVID-19

Innovating is a challenge for all organizations in the ever-changing world, requiring preparation for new contexts.

Researchers from different countries address the challenges that COVID-19 has created for educational systems

Different efficacy rates reported for how vaccines against COVID-19 may result from clinical trial designs

Webinar addressed the logistics of manufacturing and distributing the COVID-19 vaccine portfolio

Experts on social and behavioral sciences will describe how society has been coping with this threatening environment

This webinar will address a number of issues about the design of basic income policies

The 4th episode of the Research Webinars addressed the COVID-19 Data Sharing/BR repository and the challenges and benefits of COVID-19 data sharing.

Scientists around the globe are developing protocols for  a safer social and economic reopening after social distancing due to COVID-19.

Applied mathematicians have responded swiftly to the COVID-19 pandemics, integrating interdisciplinary teams and proposing models that help understanding the dynamics of the disease.

Scientists from countries with distinct local COVID-19 epidemic profiles talked about their experience in assessing transmissibility of the COVID-19 infection.